Safety and Protective Efficacy of Pb(PfCS@UIS4)

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 29, 2017

Primary Completion Date

March 28, 2018

Study Completion Date

October 3, 2018

Conditions
Malaria,FalciparumPlasmodium FalciparumPlasmodium BergheiControlled Human Malaria Infection (CHMI)
Interventions
BIOLOGICAL

Pb(PfCS@UIS4)-infected mosquitoes

Pb(PfCS@UIS4)-infected mosquitoes

OTHER

Challenge infection P. falciparum

Challenge infection with bites of five infected Pf mosquitoes

Trial Locations (2)

6525 GA

Radboud university medical center, Nijmegen

Unknown

Havenziekenhuis, Rotterdam

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Havenziekenhuis

OTHER

collaborator

Erasmus Medical Center

OTHER

collaborator

The PATH Malaria Vaccine Initiative (MVI)

OTHER

lead

Radboud University Medical Center

OTHER